Correlation Between Stepan and CERo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stepan and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stepan and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stepan Company and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Stepan and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stepan with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stepan and CERo Therapeutics.
Diversification Opportunities for Stepan and CERo Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Stepan and CERo is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Stepan Company and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Stepan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stepan Company are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Stepan i.e., Stepan and CERo Therapeutics go up and down completely randomly.
Pair Corralation between Stepan and CERo Therapeutics
Considering the 90-day investment horizon Stepan Company is expected to generate 0.05 times more return on investment than CERo Therapeutics. However, Stepan Company is 19.21 times less risky than CERo Therapeutics. It trades about -0.5 of its potential returns per unit of risk. CERo Therapeutics Holdings is currently generating about -0.03 per unit of risk. If you would invest 7,741 in Stepan Company on September 26, 2024 and sell it today you would lose (1,059) from holding Stepan Company or give up 13.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Stepan Company vs. CERo Therapeutics Holdings
Performance |
Timeline |
Stepan Company |
CERo Therapeutics |
Stepan and CERo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Stepan and CERo Therapeutics
The main advantage of trading using opposite Stepan and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stepan position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.The idea behind Stepan Company and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.CERo Therapeutics vs. Eupraxia Pharmaceuticals Common | CERo Therapeutics vs. Opus Genetics, | CERo Therapeutics vs. Telix Pharmaceuticals Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |